Literature DB >> 1869648

Neurocutaneous melanosis: definition and review of the literature.

J N Kadonaga1, I J Frieden.   

Abstract

Neurocutaneous melanosis is a rare congenital syndrome characterized by the presence of large or multiple congenital melanocytic nevi and benign or malignant pigment cell tumors of the leptomeninges. The syndrome is thought to represent an error in the morphogenesis of the embryonal neuroectoderm. We review 39 reported cases of neurocutaneous melanosis and propose revised criteria for diagnosis. Most patients with neurocutaneous melanosis presented in the first 2 years of life with neurologic manifestations of increased intracranial pressure, mass lesions, or spinal cord compression. Leptomeningeal melanoma was present in 62% of the cases, but even in the absence of melanoma, symptomatic neurocutaneous melanosis had an extremely poor prognosis. Useful diagnostic procedures include cerebrospinal fluid cytology and magnetic resonance imaging with gadolinium contrast. Patients may be aided by palliative measures such as shunt placement to reduce intracranial pressure. Dermatologists in their follow-up of patients with large or multiple congenital melanocytic nevi should be aware of this condition, to aid in prompt diagnosis and because the treatment of cutaneous lesions may be altered in the presence of symptomatic neurocutaneous melanosis.

Entities:  

Mesh:

Year:  1991        PMID: 1869648     DOI: 10.1016/0190-9622(91)70115-i

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  64 in total

1.  Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy.

Authors:  Yibing Ruan; Anna Kovalchuk; Aarthi Jayanthan; Xueqing Lun; Yoji Nagashima; Olga Kovalchuk; James R Wright; Alfredo Pinto; Adam Kirton; Ronald Anderson; Aru Narendran
Journal:  Neuro Oncol       Date:  2014-11-12       Impact factor: 12.300

Review 2.  [New aspects of congenital melanocytic nevi].

Authors:  S Krengel
Journal:  Hautarzt       Date:  2012-02       Impact factor: 0.751

3.  Neurocutaneous melanosis associated with Dandy-Walker complex and an intracranial cavernous angioma.

Authors:  Kyung Hwan Kim; Sang-Bong Chung; Doo-Sik Kong; Ho-Jun Seol; Hyung Jin Shin
Journal:  Childs Nerv Syst       Date:  2011-12-02       Impact factor: 1.475

4.  Neurocutaneous melanosis with acute disseminated encephalomyelitis.

Authors:  Takeshi Asano; Hisamitsu Hamada; Yuko Takita; Makoto Watanabe; Hanako Sugano; Mari Sudoh; Miho Yamanishi; Kentaroh Kuwabara; Taiyo Imai; Osamu Fujino
Journal:  Eur J Pediatr       Date:  2006-11-14       Impact factor: 3.183

Review 5.  A giant congenital melanocytic nevus associated with neurocutaneous melanosis.

Authors:  S J Kim; J-H Kim; B Son; C Yoo
Journal:  Clin Neuroradiol       Date:  2013-10-31       Impact factor: 3.649

6.  Ultrasonographic detection of intracranial melanocytosis in an infant.

Authors:  Jason M Johnson; L Leigh Patten; Caroline D Robson; Rita L Teele
Journal:  Pediatr Radiol       Date:  2009-09-09

7.  Central nervous system imaging and congenital melanocytic naevi.

Authors:  V A Kinsler; S E Aylett; S C Coley; W K Chong; D J Atherton
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

8.  New insights into neurocutaneous melanosis.

Authors:  Ketsuda Jakchairoongruang; Yasmin Khakoo; Mark Beckwith; A James Barkovich
Journal:  Pediatr Radiol       Date:  2018-08-03

9.  Neurocutaneous melanosis presenting as chronic partial epilepsy.

Authors:  Byoung Seok Ye; Yang-Je Cho; Sang Hyun Jang; Byung In Lee; Kyoung Heo; Hyun Ho Jung; Jin Woo Chang; Se Hoon Kim
Journal:  J Clin Neurol       Date:  2008-09-30       Impact factor: 3.077

10.  Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system.

Authors:  Heidi V N Küsters-Vandevelde; Annelies Klaasen; Benno Küsters; Patricia J T A Groenen; Ilse A C H van Engen-van Grunsven; Marcory R C F van Dijk; Guido Reifenberger; Pieter Wesseling; Willeke A M Blokx
Journal:  Acta Neuropathol       Date:  2010-03       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.